Dr. Mushtaq is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3901 Rainbow Blvd
Kansas City, KS 66160Phone+1 913-945-5793- Is this information wrong?
Summary
- Clinical investigator and physician with a focus on Hematologic Malignancies, Bone Marrow Transplant, Cellular Therapy, Immunotherapy, and Global Health
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2017 - 2020
- Cook County Health and Hospitals SystemResidency, Internal Medicine, 2014 - 2017
- Allama Iqbal Medical CollegeClass of 2010, MBBS
Certifications & Licensure
- MO State Medical License 2021 - 2025
- KS State Medical License 2020 - 2024
- WI State Medical License 2017 - 2023
- IL State Medical License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Karl and Irene Eisemann Award for Hematologic Malignancies and Cellular Therapeutics University of Kansas Medical Center, 2023
- Clinical Research Excellence Award University of Kansas Medical Center, 2023
- Robert Korngold Award for the Best Clinical Science in Cellular Therapy article American Society for Transplantation and Cellular Therapy, 2021
Clinical Trials
- Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant Start of enrollment: 2023 Dec 11
Roles: Contact, Principal Investigator
- A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD) Start of enrollment: 2023 Apr 06
- Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide Start of enrollment: 2020 Jan 31
- Join now to see all
Publications & Presentations
PubMed
- Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.Muhammad Kashif Amin, Zahra Mahmoudjafari, Matthew McGuirk, Shaun DeJarnette, Moazzam Shahzad, Polina Bellman, Joe Al-Ramahi, Jawad Noor, Abhinav Vyas, Nausheen Ahmed,...> ;Transfusion. 2024 Jun 7
- Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review.Muhammad Fareed Khalid, Muhammad Kashif Amin, Ali H Mushtaq, Atif Butt, Iqra Anwar, Moazzam Shahzad, Mohammad Ammad-Ud-Din, Usman Ilyas, Sibgha Gull Chaudhary, Naushee...> ;Hematology/oncology and Stem Cell Therapy. 2024 Mar 22
- Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience.Matthew McGuirk, Moazzam Shahzad, Muhammad Kashif Amin, Muhammad Atif Khan, Polina Bellman, Dinesh Pal Mudaranthakam, Shaun DeJarnette, Forat Lutfi, Nausheen Ahmed, Ra...> ;Transplant Immunology. 2024 Jun 1
- Join now to see all
Abstracts/Posters
- The TACTUM23 Study: Access to Cellular Therapies in Multiple Myeloma: Perspectives of Treating Versus Referring Physicians in 2023Atallah R, et al. Among other authors: Mushtaq MU, Transplantation and Cellular Therapy. 2024; 30: S375-S376, 2/2024
- The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) GloballyAtallah R, et al. Among other authors: Mushtaq MU, Transplantation and Cellular Therapy. 2024; 30: S373-S374, 2/2024
- The Glass Wall: Gendered Authorship Disparities in in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and MyelomaKhaliq A, et al. Among other authors: Mushtaq MU, Transplantation and Cellular Therapy. 2024; 30: S208, 2/2024
- Join now to see all
Lectures
- Highlights of American Society of Hematology Annual Meeting 2023. University of Kansas Cancer Center ASH ReviewKansas City, KS - 1/2024
- Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients. Grand Rounds Speaker at the University of Kansas Me...Kansas City, KS - 4/2022
- Graft failure and graft rejection. American Society of Transplantation & Cellular Therapy Fall Clinical Education Conference (ASTCT CEC)Virtual - 9/2021
- Join now to see all
Research History
- Principal InvestigatorUniversity of Kansas Cancer Center, Kansas City, KS2020 - Present
- Co-InvestigatorUniversity of Wisconsin Carbone Cancer Center, Madison, WI2017 - 2020
- Co-InvestigatorCook County Health & Hospitals System, Chicago, IL2014 - 2017
- Post-Doc Research AssociateColumbia University Irving Medical Center, New York, NY2013 - 2014
- Principal InvestigatorPunjab Department of Health/Allama Iqbal Medical College, Lahore, Pakistan2008 - 2012
- Research AssociateNew York City Department of Health and Mental Hygiene, New York, NY2010 - 2011
Professional Memberships
- Member
- Member
- Member
- American Society for Transplantation and Cellular Therapy - ASTCTMember
- Blood & Marrow Transplant Clinical Trials Network - BMT CTNMember
- Society for Immunotherapy of Cancer - SITCMember
Other Languages
- Hindi, Urdu, Punjabi
External Links
- LinkedInhttps://www.linkedin.com/in/mumushtaq/
- Google Scholarhttps://scholar.google.com/citations?hl=en&user=CzpYfMYAAAAJ
- My Bibliography (NIH)https://www.ncbi.nlm.nih.gov/myncbi/1TKnUcnWu6tQn-/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: